These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17448113)

  • 1. The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts.
    Aplin M; Christensen GL; Schneider M; Heydorn A; Gammeltoft S; Kjølbye AL; Sheikh SP; Hansen JL
    Basic Clin Pharmacol Toxicol; 2007 May; 100(5):289-95. PubMed ID: 17448113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes.
    Aplin M; Christensen GL; Schneider M; Heydorn A; Gammeltoft S; Kjølbye AL; Sheikh SP; Hansen JL
    Basic Clin Pharmacol Toxicol; 2007 May; 100(5):296-301. PubMed ID: 17448114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.
    Wang S; Gong H; Jiang G; Ye Y; Wu J; You J; Zhang G; Sun A; Komuro I; Ge J; Zou Y
    PLoS One; 2014; 9(4):e92926. PubMed ID: 24699426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes.
    Rajagopal K; Whalen EJ; Violin JD; Stiber JA; Rosenberg PB; Premont RT; Coffman TM; Rockman HA; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16284-9. PubMed ID: 17060617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionally selective AT(1) receptor activation reduces ischemia reperfusion injury.
    Hostrup A; Christensen GL; Bentzen BH; Liang B; Aplin M; Grunnet M; Hansen JL; Jespersen T
    Cell Physiol Biochem; 2012; 30(3):642-52. PubMed ID: 22854413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network.
    Kendall RT; Strungs EG; Rachidi SM; Lee MH; El-Shewy HM; Luttrell DK; Janech MG; Luttrell LM
    J Biol Chem; 2011 Jun; 286(22):19880-91. PubMed ID: 21502318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.
    Kendall RT; Lee MH; Pleasant DL; Robinson K; Kuppuswamy D; McDermott PJ; Luttrell LM
    J Biol Chem; 2014 Sep; 289(38):26155-26166. PubMed ID: 25081544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
    Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
    J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.
    Ahn S; Shenoy SK; Wei H; Lefkowitz RJ
    J Biol Chem; 2004 Aug; 279(34):35518-25. PubMed ID: 15205453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of structural determinants for G protein-independent activation of mitogen-activated protein kinases in the seventh transmembrane domain of the angiotensin II type 1 receptor.
    Yee DK; Suzuki A; Luo L; Fluharty SJ
    Mol Endocrinol; 2006 Aug; 20(8):1924-34. PubMed ID: 16556732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
    Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
    J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II activates Ca
    Kashihara T; Nakada T; Kojima K; Takeshita T; Yamada M
    J Physiol; 2017 Jul; 595(13):4207-4225. PubMed ID: 28295363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biased agonism of the angiotensin II type 1 receptor.
    Godin CM; Ferguson SS
    Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin, radixin, and moesin phosphorylation in NIH3T3 cells revealed angiotensin II type 1 receptor cell-type-dependent biased signaling.
    Ibrahim IA; Nakaya M; Kurose H
    J Pharmacol Sci; 2013; 122(1):1-9. PubMed ID: 23575451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pinocembrin inhibits angiotensin II-induced vasoconstriction via suppression of the increase of [Ca2+]i and ERK1/2 activation through blocking AT(1)R in the rat aorta.
    Li L; Pang XB; Chen BN; Gao L; Wang L; Wang SB; Wang SB; Liu DP; Du GH
    Biochem Biophys Res Commun; 2013 May; 435(1):69-75. PubMed ID: 23611777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
    Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
    J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.